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In the ‘Identification of eligible trials’ of the Results
section, we stated that a total of 1635 asthma patients
were identified from six trials. Kerstjens et al.
mention that the sum of the number of tiotropium
patients and control patients exceeds the quoted total
number of asthma patients. We acknowledge that this
was ambiguous, and would like to clarify that of the
trials that were finally included, three (Fardon et al,
Peters et al, and Kerstjens et al. 2011) were originally
designed as cross-over trials. So, although the actual
number of patients totalled 1635 (as shown in Table
1), it was natural that the sum of number of patients
from each group exceeded 1635, as patients from
cross-over trials underwent both interventions.
Finally as Drs Kerstjens and Moroni-Zentraf
indicated, we need to highlight that the baseline
FEV1(%) value from Bateman’s trial refers to the
placebo treatment arm. In addition, we would like to
correct the baseline FEV1(%) for the tiotropium
treatment arm as 74.1 6 16.12.
YEE HYUNG KIM
Department of Pulmonary and
Critical Care Medicine
Kyung Hee University Hospital at Gangdong,
Seoul, Republic of Korea
e-mail: yeehyung@gmail.com
http://dx.doi.org/10.5588/ijtld.15.0409-2
Conflicts of interest: none declared.
References
1 Lee S W, Kim H J, Yoo K H, et al. Long-acting anticholinergic
agents in patients with uncontrolled asthma: a systematic review
and meta-analysis. Int J Tuberc Lung Dis 2014; 18: 1421–1430.
Erratum in Int J Tuberc Lung Dis 2015; 19: 1267.
HIV screening in tuberculosis patients in the
northern region of Portugal
To identify determinants associated with unknown
human immunodeficiency virus (HIV) status in
tuberculosis (TB) patients in Northern Portugal, we
selected all TB cases reported from 2006 to 2012,
with no exclusion criteria. We analysed demographic
and clinical data for two groups: patients with known
and those with unknown HIV status; Northern
Portugal was divided into two subgroups, Porto
region and Other; co-morbidities were assessed as
none and one or more; and addiction comprised
alcohol and drug abuse.
Descriptive statistics are expressed as absolute
(relative) frequency for categorical variables and
mean (6 standard deviation) or median (range) for
continuous variables. The v2 or Fisher tests were used
to compare the frequencies of categorical variables;
Student’s t-test or the Mann-Whitney U-test were
used to compare means (or medians) from continuous
variables between two independent populations.
A logistic regression model was applied to identify
differences between the two groups, with a set of
predictors that was chosen after the evaluation of their
net effect on the response variable. The selection of the
best model was based on the likelihood-ratio test,
whenever possible, and on the Akaike Information
Criterion (AIC) if not. The goodness-of-fit model was
assessed by the deviance test while its discrimination
ability was given by the area under the ROC curve.
Ethical approval was not necessary as only
encrypted information was used.
Of 7683 TB patients notified, 5273 (68%) were
male, 3482 (45%) were aged between 30 and 50
years and 7420 (97%) were native born; 879 (11%)
had unknown HIV status.
Patients with unknown HIV status were more
likely to be aged .50 years (44% vs. 34%, P ,
0.001), to live outside the Porto region (68% vs.
44%, P, 0.001) and to have no co-morbidities (78%
vs. 68%, P , 0.001) or addictions (83% vs. 75%, P
,0.001). Current or past imprisonment (98% vs.
95%, P , 0.001), homelessness (97% vs. 93%, P ,
0.001) and sheltered community accommodation
(97% vs. 92%, P , 0.001) were more common in
the group with known HIV status.
In the fitted logistic regression model, unknown
HIV status was positively associated with age .50
years (OR 1.46, 95% confidence interval [CI] 1.17–
1.81) and living outside the Porto region (OR 2.77,
95%CI 2.35–3.25). Having one or more co-morbid-
ities (OR 0.72, 95%CI 0.61–0.89) or addictions
(alcohol/drug abuse) (OR 0.66, 95%CI 0.48–0.77)
was negatively associated with unknown HIV status.
Older people were less likely to have been tested for
HIV than younger people, which can be related to a
false idea that older people are less at risk. It is well
known that preconceived perceptions of risk cause
delays in diagnosis, particularly of diseases associated
with risk behaviour.1 In Portugal the proportion of
HIV patients aged .50 years has increased over the
last 20 years (.20% in 2013), despite the decrease in
HIV notifications.2
Persons outside Porto region were less likely to
have an HIV test result. We cannot exclude access to
health care as an explanation for this, as living in
rural areas or suburbs has previously been linked to
delayed diagnosis in other diseases.3
Patients identified as being at high risk, based on
social-demographic features, are more likely to
undergo HIV screening early on in life.4 HIV
screening tests are less likely to be offered by
internists to patients they believe to be at low risk,5
and risk perception of medical doctors may play an
important role in the decision of offering an HIV test
to their patients.
Knowing the importance of HIV screening in TB
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patients and our epidemiological context with high
co-infection rates, efforts are needed to attain
maximum HIV testing coverage. Risk perception
and access to health care may be barriers to be
addressed in Northern Portugal.
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XpertW MTB/RIF assay sensitivity with
different methods of CSF processing for the
diagnosis of TB meningitis
A 64-year-old woman born in India was admitted to
our hospital with headache and fever of 3 weeks,
associated with transient diplopia and dizziness. On
examination, the patient was alert with mild neck
stiffness and left fourth cranial nerve palsy. Labora-
tory tests were within normal values (including
leucocyte count and C-reactive protein, human
immunodeficiency virus negative), except for moder-
ate hyponatraemia. Magnetic resonance imaging of
the brain showed a 2 mm cerebellar lesion.
Lumbar puncture showed mononuclear pleocytosis
with low glucose concentrations and elevated pro-
teins. No acid-fast direct stain could be performed
due to the scarcity of cerebrospinal fluid (CSF). The
Xpertw MTB/RIF assay (Cepheid, Sunnyvale, CA,
USA) was initially negative for Mycobacterium
tuberculosis complex using 0.5 ml vortexed CSF. A
repeated spinal fluid sample was Xpert-positive, with
no rifampicin resistance.
An intensified regimen containing high-dose rifam-
picin, moxifloxacin, isoniazid and pyrazinamide was
started, together with dexamethasone. The following
day, the patient developed comatose mental status
related to hydrocephalus, requiring placement of a
lumbar drainage device. A large volume of CSF (30
ml) was sent for repeated investigations, as detailed
below. After the drainage and initiation of treatment,
progressive improvement in neurological status was
observed. The patient’s outcome was good, with no
neurological sequelae. Cultures were positive for
susceptible M. tuberculosis.
The performance of the Xpert assay was assessed by
evaluating fouraliquotsofCSF treateddifferentlybefore
polymerase chain reaction (PCR), as follows: aliquot 1,
0.5 ml CSF without vortexing and without centrifuga-
tion; aliquot 2, 0.5 ml CSF with vortexing and without
centrifugation; aliquot 3, a 0.5 ml pellet obtained by
centrifugation of 1 ml CSF for 10 min at 3500 3 g
followedbyvortexing; andaliquot4,0.5ml supernatant
obtained by centrifugation at the above conditions. The
PCR results are summarised in the Table.
The quantitative PCR data showed that vortexing
CSFbeforePCRseemednot toaffect the sensitivityof the
assay. However, when PCR was performed on the CSF
pellet (aliquot 3) rather than on the supernatant (aliquot
4), a difference was observed in that only the pellet
samplewas positive, and the threshold cycleswere lower
than for the non-centrifugedCSF aliquots (1 and 2), thus
further improving the sensitivity of the assay.
TB meningitis remains a difficult diagnosis, and
improvements in the sensitivity of diagnostic tools,
allowing rapid confirmation of the diagnosis, are still
needed. Sole reliance on a false-negative test result
may delay treatment initiation. Several studies have
examined the accuracy of the Xpert assay on CSF,
showing that while specificity is consistently very
high, sensitivity values are heterogeneous and depend
on sample size, tuberculosis (TB) prevalence and the
test used as gold standard.1–4 As a consequence, the
World Health Organization (WHO) has endorsed
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